Skip to content

THERAKOS, INC.

FDA registration: United States Last updated 27 May 2026

Devices
12
Registries
EUDAMEDGUDID
FDA recalls
0

Catalogue12

What THERAKOS, INC. makes

Therakos, Inc. manufactures photopheresis systems, including blood sets, system units, and lamp assemblies designed for extracorporeal photopheresis (ECP) therapy. These devices are used to treat conditions such as cutaneous T-cell lymphoma and graft-versus-host disease by exposing a patient’s blood to ultraviolet light and returning it to circulation. The primary product, the CELLEX system, integrates these components into a single therapeutic platform.

The company’s devices are classified as Class III under FDA regulations, requiring premarket approval (PMA) due to their high-risk nature. These products are listed in the FDA’s Unique Device Identifier (UDI) database, ensuring traceability and compliance with U.S. medical device regulations. The manufacturer operates within the United States, adhering to domestic regulatory standards for these authorised systems.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

How many devices does THERAKOS, INC. have in the registry?

The registry currently lists 12 devices for THERAKOS, INC.. Devices recorded under merged duplicate company entries are counted once.

Which registries list THERAKOS, INC.'s devices?

Among its 12 most recently registered devices, THERAKOS, INC. has devices listed in EUDAMED (5 devices) and FDA GUDID (12 devices). A device can be listed in more than one registry, so these counts overlap.

What risk classes do THERAKOS, INC.'s devices fall under?

Among its 12 most recently registered devices, the classes recorded for THERAKOS, INC.'s devices are Class III. Each device page shows its own class and authorisation.

What are the newest devices from THERAKOS, INC. in the registry?

The most recently registered devices listed for THERAKOS, INC. include CELLEX CLXUSA, CELLEX CLXSP-U, CELLEX CLXLGT and CELLEX CELLEXUSA.

Generated automatically from registry data and not verified by a human reviewer.

Information

FDA registration
United States(from the FDA device records)
Website
therakos.com
Phone
+1(855)422-9115
DUNS number
003083703